- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 16.12. | FDA blesses atopic dermatitis label expansions for Organon's Vtama, Galderma's Nemluvio | ||
| 13.12. | McKinsey agrees to $650M DOJ settlement over opioid consulting relationship with Purdue Pharma | ||
| 13.12. | EMA backs Merck's Welireg, Bayer's ATTR med and Gilead's liver drug from $4.3B deal | ||
| 13.12. | Avalere promotes Amar Urhekar, the architect of its new model, to CEO | ||
| 13.12. | Novo Nordisk's chief scientific officer looks to the future of GLP-1s | ||
| 13.12. | After Moderna's pediatric RSV vaccine trial hold, expert panel says more testing is needed | ||
| 12.12. | ICER calls out Gilead, J&J, Novartis and more in latest report on 'unsupported' price increases | ||
| 12.12. | Corcept shows how excess cortisol might be pulling the strings in Cushing syndrome awareness campaign | ||
| 12.12. | After M&A rumors sparked stock volatility, Bausch + Lomb confirms it's exploring a sale | ||
| 12.12. | CRO Ora showcases key role music plays in the blind community | ||
| 12.12. | Lonza plans to shed capsules business, simplify operating structure in push to become 'pure-play' CDMO | ||
| 12.12. | Siga's smallpox antiviral Tpoxx misses the mark in another mpox study | ||
| 12.12. | SABCS: Under siege from competitors, Pfizer's Ibrance scores in double-positive breast cancer | ||
| 12.12. | Ex-NFL stars 'Gear Up' with CDC for colorectal cancer screening push | ||
| 11.12. | Trump names Andrew Ferguson as pick for FTC chair in potential win for biopharma dealmaking | ||
| 11.12. | With Biktarvy patent cliff ahead, Gilead lays out a plan to keep the HIV crown with 7 launches through 2033 | ||
| 11.12. | Lilly CEO Ricks provides hints on how Trump will approach healthcare issues | ||
| 11.12. | Vertex, Saudi Arabia ink memorandum of understanding to boost local gene therapy manufacturing | ||
| 11.12. | Daiichi Sankyo builds $152M ADC plant in China as Enhertu wins national coverage | ||
| 10.12. | CSL Vifor floats £23M offer, doctor outreach campaign in bid to resolve UK antitrust probe | ||
| 10.12. | High-flying Eli Lilly plots $15B share buyback plan | ||
| 10.12. | ASH: Eli Lilly touts novel BTK trial win for Jaypirca as execs defend survival data blemish | ||
| 09.12. | EuroAPI vaults operating chief into CEO role as it embarks upon 'new chapter' | ||
| 09.12. | Boehringer, Lilly bring 'It Takes 2' kidney disease testing push to 2025 Rose Parade | ||
| 09.12. | BioMarin to add €60M lab to Irish manufacturing site in push to grow production capacity |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
